Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis

Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized)...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of respiratory and critical care medicine 1999-09, Vol.160 (3), p.796-801
Hauptverfasser: STITES, S. W, PLAUTZ, M. W, BAILEY, K, O'BRIEN-LADNER, A. R, WESSELIUS, L. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 801
container_issue 3
container_start_page 796
container_title American journal of respiratory and critical care medicine
container_volume 160
creator STITES, S. W
PLAUTZ, M. W
BAILEY, K
O'BRIEN-LADNER, A. R
WESSELIUS, L. J
description Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p < 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p < 0.005) or NS (9 +/- 3 ng/ml, p < 0.0005). Ferritin recovered from HS and NS lungs was < 2% H type, whereas ferritin in CF lungs was > 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.
doi_str_mv 10.1164/ajrccm.160.3.9811018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70009621</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70009621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</originalsourceid><addsrcrecordid>eNpNkMtqHDEQRYWJ8Sv5gxC0CNn1pKoldbeWweRhMHgTQ3ZCrZawTI80UWlw5u8jMwPJSgU691J1GHuPsEEc5Gf7XJzbbnCAjdjoCRFwOmNXqITqpB7hTZthFJ2U-tcluyZ6BsB-QrhglwhyRKX1Fftzl1zxlvzCXU7Op1psjTkRz4HHkhO3aeGRcvClxBrbR0y8Pnm-5hdfePG0iy2Sy4G3qKuvuV2raE3EX2J94lTtvHruDlSj4yHOJVOkt-w82JX8u9N7wx6_ff15-6O7f_h-d_vlvnNC9LXzQk9SLTAI5XCxutcaQc9Tj6Gf9KRhnAGXWQk7KHChHT8NTgYRpgH7ZZTihn069u5K_r33VM02kvPrapPPezIjAOihxwbKI-jaflR8MLsSt7YcDIJ5NW6Oxk0zboQ5GW-xD6f-_bz1y3-ho-IGfDwBlpxdQ7HJRfrHaaXGAcVfTDiMdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70009621</pqid></control><display><type>article</type><title>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</title><source>Journals@Ovid Complete - AutoHoldings</source><source>MEDLINE</source><source>American Thoracic Society Journals</source><source>EZB Electronic Journals Library</source><creator>STITES, S. W ; PLAUTZ, M. W ; BAILEY, K ; O'BRIEN-LADNER, A. R ; WESSELIUS, L. J</creator><creatorcontrib>STITES, S. W ; PLAUTZ, M. W ; BAILEY, K ; O'BRIEN-LADNER, A. R ; WESSELIUS, L. J</creatorcontrib><description>Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p &lt; 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p &lt; 0.005) or NS (9 +/- 3 ng/ml, p &lt; 0.0005). Ferritin recovered from HS and NS lungs was &lt; 2% H type, whereas ferritin in CF lungs was &gt; 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.160.3.9811018</identifier><identifier>PMID: 10471599</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject>Adult ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - chemistry ; Bronchoalveolar Lavage Fluid - cytology ; Cell Count ; Chronic Disease ; Cystic Fibrosis - metabolism ; Enzyme-Linked Immunosorbent Assay ; Female ; Ferritins - metabolism ; Humans ; Iron - metabolism ; Male ; Medical sciences ; Pneumology ; Proteins - metabolism ; Respiratory system : syndromes and miscellaneous diseases ; Smoking - adverse effects ; Statistics, Nonparametric ; Transferrin - metabolism ; Tumor Cells, Cultured - metabolism ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>American journal of respiratory and critical care medicine, 1999-09, Vol.160 (3), p.796-801</ispartof><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</citedby><cites>FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4011,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1955761$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10471599$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>STITES, S. W</creatorcontrib><creatorcontrib>PLAUTZ, M. W</creatorcontrib><creatorcontrib>BAILEY, K</creatorcontrib><creatorcontrib>O'BRIEN-LADNER, A. R</creatorcontrib><creatorcontrib>WESSELIUS, L. J</creatorcontrib><title>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p &lt; 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p &lt; 0.005) or NS (9 +/- 3 ng/ml, p &lt; 0.0005). Ferritin recovered from HS and NS lungs was &lt; 2% H type, whereas ferritin in CF lungs was &gt; 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - chemistry</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Cell Count</subject><subject>Chronic Disease</subject><subject>Cystic Fibrosis - metabolism</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Ferritins - metabolism</subject><subject>Humans</subject><subject>Iron - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pneumology</subject><subject>Proteins - metabolism</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Smoking - adverse effects</subject><subject>Statistics, Nonparametric</subject><subject>Transferrin - metabolism</subject><subject>Tumor Cells, Cultured - metabolism</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMtqHDEQRYWJ8Sv5gxC0CNn1pKoldbeWweRhMHgTQ3ZCrZawTI80UWlw5u8jMwPJSgU691J1GHuPsEEc5Gf7XJzbbnCAjdjoCRFwOmNXqITqpB7hTZthFJ2U-tcluyZ6BsB-QrhglwhyRKX1Fftzl1zxlvzCXU7Op1psjTkRz4HHkhO3aeGRcvClxBrbR0y8Pnm-5hdfePG0iy2Sy4G3qKuvuV2raE3EX2J94lTtvHruDlSj4yHOJVOkt-w82JX8u9N7wx6_ff15-6O7f_h-d_vlvnNC9LXzQk9SLTAI5XCxutcaQc9Tj6Gf9KRhnAGXWQk7KHChHT8NTgYRpgH7ZZTihn069u5K_r33VM02kvPrapPPezIjAOihxwbKI-jaflR8MLsSt7YcDIJ5NW6Oxk0zboQ5GW-xD6f-_bz1y3-ho-IGfDwBlpxdQ7HJRfrHaaXGAcVfTDiMdw</recordid><startdate>19990901</startdate><enddate>19990901</enddate><creator>STITES, S. W</creator><creator>PLAUTZ, M. W</creator><creator>BAILEY, K</creator><creator>O'BRIEN-LADNER, A. R</creator><creator>WESSELIUS, L. J</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990901</creationdate><title>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</title><author>STITES, S. W ; PLAUTZ, M. W ; BAILEY, K ; O'BRIEN-LADNER, A. R ; WESSELIUS, L. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-e39845d0635c1da9299109b821f2898907b01db53a650cf53586c4f3f8612d743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - chemistry</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Cell Count</topic><topic>Chronic Disease</topic><topic>Cystic Fibrosis - metabolism</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Ferritins - metabolism</topic><topic>Humans</topic><topic>Iron - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pneumology</topic><topic>Proteins - metabolism</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Smoking - adverse effects</topic><topic>Statistics, Nonparametric</topic><topic>Transferrin - metabolism</topic><topic>Tumor Cells, Cultured - metabolism</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>STITES, S. W</creatorcontrib><creatorcontrib>PLAUTZ, M. W</creatorcontrib><creatorcontrib>BAILEY, K</creatorcontrib><creatorcontrib>O'BRIEN-LADNER, A. R</creatorcontrib><creatorcontrib>WESSELIUS, L. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>STITES, S. W</au><au>PLAUTZ, M. W</au><au>BAILEY, K</au><au>O'BRIEN-LADNER, A. R</au><au>WESSELIUS, L. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1999-09-01</date><risdate>1999</risdate><volume>160</volume><issue>3</issue><spage>796</spage><epage>801</epage><pages>796-801</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Reactive oxygen species may contribute to airway injury in patients with cystic fibrosis (CF) and iron catalyzes oxidant injury by promoting generation of highly reactive hydroxyl radicals. Iron in the lower respiratory tract may be free, ferritin bound (from which iron can be reductively mobilized), or transferrin bound (which generally prevents iron mobilization). Ferritin is composed of subunits that are heavy (H) or light (L), and H-rich ferritins have additional biologic effects including inhibition of lymphocyte proliferation and cell growth. To assess concentrations of iron and iron-binding proteins in the lower respiratory tract of patients with CF, we measured iron (ferrozine), L-ferritin, H-ferritin, and transferrin (enzyme-linked immunosorbent assay [ELISA]) in bronchoalveolar lavage (BAL) fluid recovered from stable patients with CF (n = 8), healthy nonsmokers (NS; n = 8), or heavy cigarette smokers (HS; n = 8). Iron was detected in BAL fluid from patients with CF and HS, but not NS, with higher iron concentrations in patients with CF (42.0 +/- 11.6 microgram/dl) than in HS (9.9 +/- 2.6 microgram/dl, p &lt; 0.05). Ferritin was present in all BAL fluids, with higher total ferritin (L + H) in patients with CF (647 +/- 84 ng/ml) than in HS (181 +/- 25 ng/ml, p &lt; 0.005) or NS (9 +/- 3 ng/ml, p &lt; 0.0005). Ferritin recovered from HS and NS lungs was &lt; 2% H type, whereas ferritin in CF lungs was &gt; 40% H-type ferritin. Transferrin concentrations in BAL fluid were not different in any group. Tumor necrosis factor (TNF)-alpha was present only in BAL samples from patients with CF. To assess whether TNF-alpha contributed to H-ferritin accumulation in CF lungs, we treated lung epithelial cells (A549) with iron alone (FeSO(4), 10-40 microM) or with iron and TNF-alpha (5-20 ng/ml). Iron-treated A549 cells synthesized almost entirely L-ferritin whereas exposure to TNF-alpha with iron caused a dose-dependent increase in accumulation of H-type ferritin. These findings suggest that oxidant injury could be promoted in lungs of patients with cystic fibrosis by iron mobilized from extracellular ferritin and, in addition, that TNF-alpha-promoted accumulation of H-type ferritin may impair local immune function and cell growth.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>10471599</pmid><doi>10.1164/ajrccm.160.3.9811018</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 1999-09, Vol.160 (3), p.796-801
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_miscellaneous_70009621
source Journals@Ovid Complete - AutoHoldings; MEDLINE; American Thoracic Society Journals; EZB Electronic Journals Library
subjects Adult
Biological and medical sciences
Bronchoalveolar Lavage Fluid - chemistry
Bronchoalveolar Lavage Fluid - cytology
Cell Count
Chronic Disease
Cystic Fibrosis - metabolism
Enzyme-Linked Immunosorbent Assay
Female
Ferritins - metabolism
Humans
Iron - metabolism
Male
Medical sciences
Pneumology
Proteins - metabolism
Respiratory system : syndromes and miscellaneous diseases
Smoking - adverse effects
Statistics, Nonparametric
Transferrin - metabolism
Tumor Cells, Cultured - metabolism
Tumor Necrosis Factor-alpha - metabolism
title Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A06%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20concentrations%20of%20iron%20and%20isoferritins%20in%20the%20lower%20respiratory%20tract%20of%20patients%20with%20stable%20cystic%20fibrosis&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=STITES,%20S.%20W&rft.date=1999-09-01&rft.volume=160&rft.issue=3&rft.spage=796&rft.epage=801&rft.pages=796-801&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.160.3.9811018&rft_dat=%3Cproquest_cross%3E70009621%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70009621&rft_id=info:pmid/10471599&rfr_iscdi=true